Market capitalization | $560.00k |
Enterprise Value | $6.49b |
P/E (TTM) P/E ratio | 0.00 |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.28 |
P/S ratio (TTM) P/S ratio | 0.00 |
P/B ratio (TTM) P/B ratio | 0.00 |
Revenue growth (TTM) Revenue growth | -3.03% |
Revenue (TTM) Revenue | $23.48b |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
1 Analyst has issued a forecast Rite Aid Corporation:
1 Analyst has issued a forecast Rite Aid Corporation:
Aug '23 |
+/-
%
|
||
Revenue | 23,475 23,475 |
3%
3%
|
|
Gross Profit | 4,671 4,671 |
4%
4%
|
|
EBITDA | 264 264 |
31%
31%
|
EBIT (Operating Income) EBIT | -8.83 -8.83 |
109%
109%
|
Net Profit | -1,625 -1,625 |
87%
87%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services business segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass in September 1962 and is headquartered in Camp Hill, PA.
Head office | United States |
CEO | Matthew Schroeder |
Employees | 47,000 |
Founded | 1962 |
Website | www.riteaid.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.